Real-time cardiac safety monitoring during drug therapy, trained on sparse clinical trial data to detect patient-specific risk signals that traditional approaches miss.
Medical solutions
by Ammonix
WaveMedix applies the Ammonix architecture to clinical decisions: auditable, safe and inside your walls.
See how a single patient finds their place in a clinical universe.
15 Aug 2025
HR 72QT 392Sinus
Note · 15 Aug 2025
65-year-old male presents with intermittent palpitations and mild fatigue…
22 Oct 2025
HR 75QT 431Sinus + PVCs
Note · 22 Oct 2025
Follow-up after starting amiodarone. Patient reports occasional dizziness…
07 Jan 2026
HR 78QT 452AFib
Note · 07 Jan 2026
Routine surveillance. Patient endorses chest tightness on exertion…
Applications
Deploying intelligent systems where clinical decisions matter most
We do more than deliver software. Our forward deployed engineers integrate each system on site in weeks, without the long and expensive technology transfers of conventional deployments. Direct collaboration means real impact from day one.
Effective with limited clinical trial data
Personalized risk assessment for each patient
Regulatory pathway: CE Mark and FDA 510(k)
Rapid identification of critical first-line lab parameters in highly time-sensitive situations with limited sample availability, augmenting clinical decision-making when every second counts.
Critical values in seconds, not minutes
Reduced cognitive load during triage
Integration with existing lab systems
An agentic system providing real-time procedural guidance during electrophysiology procedures, supporting clinicians with intelligent decision support throughout the procedure.
Real-time procedural guidance and alerts
Workflow-integrated decision support
Institutional knowledge over time
About us
Who we are
Francesca Stingele and Peter Ruppersberg have collaborated for more than 15 years in the development, validation, and commercialization of medical technologies. Their joint work spans the full medical-device lifecycle, including clinical concept definition, system and product development, regulatory strategy and execution, quality-aligned scale-up, and international market introduction, most recently resulting in the acquisition of their previous company by a global medical-technology organization.
At WaveMedix, Francesca and Peter are building AI that actually works in clinical reality: locally deployed agentic systems, built on transparent, outcome-trained models specialized for the sparse, complex data of real medicine. All WaveMedix applications are built on the Ammonix architecture and were its first flagship applications.
